Company Overview
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, Mexico, and internationally. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; Neuragen a homeopathic product; and UrgentRx, an over the counter drug. It sells its products through club, mass drug, and other retailers. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. The company was incorporated in 2010 and is based in Windham, Maine.
Why Investors Should Care
Generates a return on equity of 53.4%, reflecting efficient use of shareholder capital.
Revenue has grown at a 175.5% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $30.38M (-12.8% YoY); net profit $-12.34M.
- Trailing 12 Months Year-on-year growth — revenue -32.8%, earnings -680.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 175.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 175.49% |
| 1 Year: | -32.80% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -680.77% |
Stock Price Performance
| 1 Year: | -97.84% |
| 6 Months: | -93.65% |
| 3 Months: | -60.00% |
| 1 Month: | -50.48% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)32.19 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 53.4%.
- Compounding revenue at 175.5% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 97.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SNYR Synergy CHC Corp. PHARMA | 0.08 | -0.05 | $1.19M | 0.00% | -93.25% | 53.36% | 175.49% | - |
| 2 | LLY Eli Lilly and Company SPXR3KPHARMA | 1,123.91 | 37.80 | $1.00T | 0.60% | - | 102.29% | 7.20% | 11.41% |
| 3 | JNJ Johnson & Johnson SPXR3KPHARMA | 269.12 | 31.22 | $648.55B | 1.98% | 14.88% | 25.74% | 2.43% | 4.76% |
| 4 | ABBV AbbVie Inc. SPXR3KPHARMA | 248.78 | 70.48 | $439.62B | 2.78% | 10.47% | -129.24% | 1.75% | -29.06% |
| 5 | MRK Merck & Co., Inc. SPXR3KPHARMA | 148.46 | 118.77 | $366.28B | 2.31% | - | 6.96% | 5.64% | 10.01% |
| 6 | UNH UnitedHealth Group Incorporated SPXR3KPHARMA | 400.84 | 25.74 | $359.79B | 2.47% | 9.74% | 14.15% | 10.40% | 5.43% |
| 7 | NVS Novartis AG PHARMA | 137.70 | 20.80 | $261.73B | 3.36% | 21.09% | 30.35% | 9.25% | 26.22% |
| 8 | AZN AstraZeneca PLC NDXPHARMA | 160.04 | 23.99 | $248.20B | 2.00% | 15.97% | 21.96% | 9.82% | 45.96% |
| 9 | TMO Thermo Fisher Scientific Inc. SPXR3KPHARMA | 603.02 | 32.49 | $222.97B | 0.29% | 8.14% | 13.51% | 8.81% | 12.95% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Oct 2012 | Jan 2013 | Mar 2013 | Apr 2013 | Jun 2013 | Sep 2013 | Oct 2013 | Jan 2014 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.32M | 9.18M | 9.70M | 9.73M | 9.19M | 9.47M | 6.34M | 7.36M | 6.12M | - | - | - | - | - | - | - | 8.17M | 8.13M | 8.01M | 6.07M | 5.49M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.01M | 1.90M | 2.33M | 3.85M | 1.52M |
| Gross Profit | - | - | - | - | - | - | - | - | - | 1.06K | - | 994.97K | 1.43M | 1.71M | 6.23M | 6.09M | 8.09M | 8.29M | 6.86M | 6.52M | 6.89M | 6.98M | 6.24M | 6.93M | 4.73M | 4.87M | 4.62M | - | - | 7.78M | 6.77M | 5.58M | 4.79M | - | 6.16M | 6.24M | 5.68M | 2.22M | 3.97M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.22M | 4.61M | 4.40M | 8.87M | 4.54M |
| Operating Income | - | - | - | - | - | - | - | - | -2.07K | -642.49K | -142.24K | -130.68K | 259.76K | 87.16K | 2.64M | 1.93M | 2.93M | 3.16M | -92.30K | 444.94K | 425.91K | -95.94K | 639.60K | 1.82M | 705.45K | 363.21K | 1.01M | - | - | 2.15M | 1.81M | 1.58M | 1.05M | - | 1.95M | 1.62M | 1.28M | -6.65M | -567.12K |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.99M | 3.80M | 1.31M | -13.27M | -537.16K |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.10M | 2.11M | 1.16M | 1.57M | 2.01M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 864.80K | 1.66M | 114.22K | -14.87M | -2.58M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -11.46K | 190.11K | -11.11K | -50.07K | -13.72K |
| Net Income | -1.84K | -6.20K | -7.03K | -2.80K | -2.17K | -14.61K | -8.41K | -20.68K | -2.07K | -642.49K | -142.24K | -2.42M | -186.14K | -467.61K | 2.81M | -12.59K | 3.05M | 2.56M | -50.18K | 127.49K | -55.49K | -783.39K | 345.59K | 1.47M | 318.46K | 107.86K | 262.30K | 328.43K | 2.13M | 1.28M | 580.53K | 655.19K | 783.59K | - | 876.26K | 1.47M | 125.33K | -14.82M | -2.57M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | -0.04 | 0.00 | -0.01 | 0.03 | 0.00 | 0.04 | 0.03 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | - | - | 0.17 | 0.08 | 0.09 | 0.11 | - | 0.10 | 0.17 | 0.01 | - | -0.23 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jul 2012 | Jul 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | 9.16K | 13.46M | 34.84M | 35.60M | 33.82M | 29.36M | 42.78M | 34.83M | 30.38M |
| Cost of Revenue | - | - | - | - | - | - | - | - | 10.70M | 11.19M | 10.08M |
| Gross Profit | - | - | 3.54K | 8.15M | 24.64M | 25.78M | 22.79M | 20.22M | 32.08M | 23.64M | 20.30M |
| Operating Expenses | - | - | - | - | - | - | - | - | 21.27M | 17.84M | 22.10M |
| Operating Income | - | - | -958.09K | 486.02K | 2.93M | 1.82M | -4.92M | -7.96M | 10.81M | 5.80M | -1.80M |
| EBITDA | - | - | - | - | - | - | - | - | 10.84M | 6.47M | -6.17M |
| Interest Expense | - | - | - | - | - | - | - | - | 4.24M | 4.11M | 5.92M |
| Pretax Income | - | - | - | - | - | - | - | - | 6.57M | 2.23M | -12.22M |
| Tax Provision | - | - | - | - | - | - | - | - | 234.98K | 102.08K | 117.47K |
| Net Income | -16.20K | -23.20K | -960.09K | -7.54M | -796.16K | 499.57K | -6.16M | -9.21M | 6.34M | 2.12M | -12.34M |
| Diluted EPS | - | - | - | - | - | 0.01 | -0.07 | -0.10 | 0.86 | 0.28 | -1.27 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jul 2012 | Jul 2013 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 4.00K | 33.91K | 3.23K | 55.38K | 26.76M | 20.46M | 24.03M | 20.01M | 5.19M | - | 12.24M | 16.34M | 10.16M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | 11.82M | 16.06M | 10.01M |
| Cash & Equivalents | 4.00K | 33.91K | 3.23K | 338 | 3.64M | 2.52M | 1.96M | 459.74K | 1.22M | - | 632.53K | 687.92K | 2.62M |
| Inventory | - | - | - | - | - | - | - | - | - | - | 3.73M | 1.72M | 3.74M |
| Receivables | - | - | - | - | - | - | - | - | - | - | 2.11M | 5.32M | 3.20M |
| Total Liabilities | 18.00K | 23.69K | - | 181.04K | 21.34M | 13.35M | 14.60M | 16.04M | 10.39M | - | 39.55M | 32.97M | 33.29M |
| Current Liabilities | - | 23.69K | 16.05K | 181.04K | 15.37M | 12.21M | 7.14M | 10.41M | 10.15M | - | 14.02M | 17.18M | 8.24M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | 25.52M | 15.79M | 25.06M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | 27.62M | 27.52M | 26.81M |
| Total Equity | -14.00K | 10.22K | -12.82K | -125.67K | 5.42M | 7.11M | 9.43M | 3.97M | -5.20M | -33.52M | -27.31M | -16.63M | -23.13M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 7.55M | 8.72M | 11.48M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jul 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.78K | -489.18K | -644.32K | 6.04M | -831.07K | 1.30M | 2.95M | 421.73K | -4.80M | -2.59M |
| Investing Cash Flow | - | - | -4.40M | -2.35M | -1.91M | -198.01K | - | 0 | 0 | 0 |
| Financing Cash Flow | 45.69K | 486.28K | 8.68M | -4.83M | 2.31M | -2.86M | -2.05M | -2.09M | 4.80M | 4.65M |
| Capital Expenditure | - | - | -7.83K | -302.23K | -153.02K | -129.09K | - | - | - | - |
| Free Cash Flow | - | - | -652.15K | 5.74M | -984.09K | 1.18M | - | 421.73K | -4.80M | -2.59M |
| Net Change in Cash | - | - | - | - | - | - | - | -1.67M | 696 | 2.07M |
| Dividends Paid | - | - | 1.17M | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Jul 2012 | Jul 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | 38.7% | 60.6% | 70.7% | 72.4% | 67.4% | 68.9% | 75.0% | 67.9% | 66.8% |
| Operating Margin % | - | - | -10,461.8% | 3.6% | 8.4% | 5.1% | -14.5% | -27.1% | 25.3% | 16.7% | -5.9% |
| Net Margin % | - | - | -10,483.6% | -56.0% | -2.3% | 1.4% | -18.2% | -31.4% | 14.8% | 6.1% | -40.6% |
| ROE % | 115.7% | -227.1% | 764.0% | -139.1% | -11.2% | 5.3% | -155.2% | 177.0% | -23.2% | -12.8% | 53.4% |
| ROCE % | - | - | 762.4% | 4.3% | 35.6% | 10.8% | -51.2% | 160.5% | -606.3% | -689.6% | -93.2% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Jane Street Group, LLC | 2.40% | 181.65K | $16.44K |
| 2 | ACT Advisors, LLC. | 2.01% | 151.84K | $13.74K |
| 3 | SOA Wealth Advisors, LLC | 1.10% | 83.08K | $7.52K |
| 4 | Xtx Topco Ltd | 0.81% | 61.27K | $5.54K |
| 5 | Vanguard Capital Management LLC | 0.52% | 38.91K | $3.52K |
| 6 | HRT Financial LP | 0.45% | 34.03K | $3.08K |
| 7 | Geode Capital Management, LLC | 0.43% | 32.77K | $2.97K |
| 8 | Virtu Financial LLC | 0.25% | 18.54K | $1.68K |
| 9 | Vanguard Fiduciary Trust Co | 0.21% | 16.01K | $1.45K |
| 10 | Stonex Group Inc. | 0.20% | 15.11K | $1.37K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SNYR
Synergy CHC Corp. Receives Nasdaq Non-Compliance Notice Over Delayed Q2 2026 Form 10-Q Filing - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxNMHFCbjh2cmNqb0t1OUllVHNqU3JPend2SEpPSDdYNmtWMy1Ib3huWkQ0OFVObXBRWjM1VGxfY09jZWJyU3ZBejRXRGxwdmNlZkpZa1p2ZHlTVHUxY1hiWlQ5b3VWR3hKU1VzS3Znb08yZlhKMnF2Zl9WdU9rX2dERXc2cjJPREVma2RTSG…
SNYR Forecast — Price Target — Prediction for 2027 - tradingview.com
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE9RdzlHYWZ0Tl9uakVwa1FraEkwYUZ4Nk0ybGp2UnQ1ZFh4MjZuc1d3ZXlDclR6YkxLSWFyV2lvMGxsSFBhRGZFdm9Ob0N1VlI0T1N5NU1lSnZheDQtV0UxNWdrYTRQQk9vQmNCNUxkc2pYSnJmSGdSLVp3?oc=5" target="_blank">SNY…
Synergy CHC Corp. Common Stock (NASDAQ: SNYR) Stock Price, News & Analysis - kalkine.com.au
<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTFBoLWc5SU1rSzZTS3g3Q2pyeG9SYWxoVE1faFMydU5hQXpwaktwMVJacWlRQUhFa3NjVXgzOHpJM0lGY0ltLWtmb2ZuYkc2ZDhGVWhOX0Vn?oc=5" target="_blank">Synergy CHC Corp. Common Stock (NASDAQ: SNYR) Stock…
Synergy CHC Corp. (SNYR) Reports Q1 Loss, Misses Revenue Estimates - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQeENaSTlPdk5sRHplNlQ1c09HeVVpblVweFdVa1M0TjZsYzl3eExnclJyMFVrTHI2dWt3ZGR2ZjFTRXZ2T0JzUUtQQVN4VzBNc1VTa2hwUkJwYkozZDJWTUJPWHI0WkVWNk41SUVuR2F5cGh1WkZ5WVFtbWJlaVM3OGNjRXFUS2FhcjdpRT…
SNYR - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE92ZXE2V3ltTnludk9FTTRPQlF5Yi1SclNqNWRWLW1ldHRkS3pGdUkzRVlpaS1VVXdWSXZkdmIyckFmSklIWHc?oc=5" target="_blank">SNYR</a> <font color="#6f6f6f">Finviz</font>…
Insider Buyers Lose Additional US$75k As Synergy CHC Dips To US$2.7m - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxNQXhGM3ZQYkN4RUVlalpZVy1UcjNpeXpfQVNFelBqV3d0Njhhd3FqZi0ydDFfZDV2V2lUbzlHb290YVhNQTloQTRJWWtsTDlXV0JXZjdVNGJnMURyZ1JEeS1tRFN6OUcxZDJnUWdrVlVMNlVNV3MwN2V1d25IdVJXSWh2QnlSRUE2eDE2WE…
SNYR — Frequently Asked Questions
What is the current share price of Synergy CHC Corp. (SNYR)?
As of 2026-09-19 21:16 PDT, Synergy CHC Corp. (SNYR) trades at $0.08 on NasdaqCM. Its 52-week range is $0.08 to $3.86.
What is the market capitalisation of SNYR?
Synergy CHC Corp. (SNYR) has a market capitalisation of $1.19M on NasdaqCM.
What is the P/E ratio of SNYR?
SNYR trades at a trailing price-to-earnings (P/E) ratio of -0.05. The industry average P/E is 24.83. Its price-to-book (P/B) ratio is -0.04.
What is the return on equity (ROE) of SNYR?
SNYR has a return on equity (ROE) of 53.36%. Its return on capital employed (ROCE) is -93.25%.
Is SNYR a good stock to buy?
This page provides a data-driven analysis of Synergy CHC Corp. (SNYR), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.